NHI Q4 net income $0.04/diluted share; new $160M buyback; 2023 FFO guidance $4.24-$4.30

NATIONAL HEALTH INVESTORS INC

2022-FY EPS reported $1.48 revenue$278,194,000

Q4 2022 net income $0.04/diluted share vs $0.14 YoY; full year $1.48 vs $2.44.
NAREIT FFO per diluted share Q4 $0.74 vs $1.07; full year $3.55 vs $4.62.
Q4 loan and realty losses $22.0M including $8.7M credit loss reserve and $13.3M impairments.
New $160M stock repurchase plan replaces $240M plan; 2.5M shares repurchased at avg $61.56 in 2022.
2023 guidance: NAREIT FFO per diluted share $4.24-$4.30; Normalized FAD $185.3-$187.9M.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NATIONAL HEALTH INVESTORS INC reported financial results for the three months and year ended December 31, 2022.

Period: the three months and year ended December 31, 2022
Result: reported results

Exact text from the filing

On February 21, 2023, National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

NATIONAL HEALTH INVESTORS INC filing history →

Source: SEC EDGAR

accession 0000877860-23-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.